Search

Veligrotug (Viridian Therapeutics Inc.) for Thyroid Eye Disease

An intravenously administered insulin-like growth factor-1 receptor (IGF-1R) inhibitor for the treatment of thyroid eye disease (TED).

Complete this form to request the full report